Vital Signs: Deaths Among Persons with Diagnosed HIV Infection, United States, 2010-2018.

Vital Signs: Deaths Among Persons with Diagnosed HIV Infection, United States, 2010-2018.
复制标题

DOI:
10.15585/mmwr.mm6946a1
复制
发表时间:
2020-11-20
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
通讯作者:
Hall HI
Hall HI
中科院分区:
其他
文献类型:
--
作者:
Bosh KA;Johnson AS;Hernandez AL;Prejean J;Taylor J;Wingard R;Valleroy LA;Hall HI

文献摘要

参考文献

被引文献

相似文献

接受推荐治疗的人体免疫缺陷病毒(艾滋病毒)感染者的预期寿命可接近一般人群的预期寿命,但艾滋病毒仍然是某些人群的十大死亡原因之一。利用监测数据,疾病预防控制中心评估了在减少艾滋病毒感染者(PWDH)死亡方面取得的进展。疾病预防控制中心分析了≥13岁人群的国家艾滋病毒监测系统数据,以确定2010-2018年期间每1000名PWDH的年龄调整死亡率。使用《国际疾病分类第十版》,未遗漏潜在原因的死亡被分类为与艾滋病毒相关或与非艾滋病毒相关。计算2010 - 2018年总死亡人数和2010 - 2017年死因死亡人数(2018年因报告延迟而排除在外)、人口统计学特征、传播类别和死亡时美国人口普查居住地区的时间变化。2010-2018年期间,死亡率总体下降了36.6%(从19.4‰降至12.3‰)。2010-2017年期间,艾滋病毒相关死亡率下降了48.4%(从9.1降至4.7),而非艾滋病毒相关死亡率下降了8.6%(从9.3降至8.5)。2017年艾滋病毒相关死亡率按种族/族裔划分最高的是多种族人群(7.0)和黑人/非洲裔美国人(5.6),其次是白人(3.9)和西班牙裔/拉丁裔(3.9)。与艾滋病毒有关的死亡率在南部最高(6.0),在东北部最低(3.2)。早期诊断、及时治疗和保持获得高质量护理和治疗的机会成功地减少了与艾滋病毒有关的死亡,并且仍然是继续减少与艾滋病毒有关的死亡的必要条件。
Life expectancy for persons with human immunodeficiency virus (HIV) infection who receive recommended treatment can approach that of the general population, yet HIV remains among the 10 leading causes of death among certain populations. Using surveillance data, CDC assessed progress toward reducing deaths among persons with diagnosed HIV (PWDH). CDC analyzed National HIV Surveillance System data for persons aged ≥13 years to determine age-adjusted death rates per 1,000 PWDH during 2010–2018. Using the International Classification of Diseases, Tenth Revision, deaths with a nonmissing underlying cause were classified as HIV-related or non–HIV-related. Temporal changes in total deaths during 2010−2018 and deaths by cause during 2010–2017 (2018 excluded because of delays in reporting), by demographic characteristics, transmission category, and U.S. Census region of residence at time of death were calculated. During 2010–2018, rates of death decreased by 36.6% overall (from 19.4 to 12.3 per 1,000 PWDH). During 2010–2017, HIV-related death rates decreased 48.4% (from 9.1 to 4.7), whereas non–HIV-related death rates decreased 8.6% (from 9.3 to 8.5). Rates of HIV-related deaths during 2017 were highest by race/ethnicity among persons of multiple races (7.0) and Black/African American persons (5.6), followed by White persons (3.9) and Hispanic/Latino persons (3.9). The HIV-related death rate was highest in the South (6.0) and lowest in the Northeast (3.2). Early diagnosis, prompt treatment, and maintaining access to high-quality care and treatment have been successful in reducing HIV-related deaths and remain necessary for continuing reductions in HIV-related deaths.
DOI: 10.15585/mmwr.mm6647e1
发表时间: 2017-12-01
期刊: MMWR. Morbidity and mortality weekly report
影响因子: --
作者:
Dailey AF;Hoots BE;Hall HI;Song R;Hayes D;Fulton P Jr;Prejean J;Hernandez AL;Koenig LJ;Valleroy LA
通讯作者: Valleroy LA
DOI: 10.15585/mmwr.mm6848e1
发表时间: 2019-12-06
影响因子: 33.9
作者:
Harris, Norma S.;Johnson, Anna Satcher;Hall, H. Irene
通讯作者: Hall, H. Irene
DOI: 10.1097/qai.0000000000002398
发表时间: 2020-09-01
期刊: Journal of acquired immune deficiency syndromes (1999)
影响因子: --
作者:
通讯作者: --
DOI: 10.1080/09540121.2015.1069786
发表时间: 2016
期刊: AIDS care
影响因子: 1.7
作者:
Trepka MJ;Sheehan DM;Fennie KP;Niyonsenga T;Lieb S;Maddox LM
通讯作者: Maddox LM
DOI: 10.1371/journal.pone.0081355
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者:
Samji H;Cescon A;Hogg RS;Modur SP;Althoff KN;Buchacz K;Burchell AN;Cohen M;Gebo KA;Gill MJ;Justice A;Kirk G;Klein MB;Korthuis PT;Martin J;Napravnik S;Rourke SB;Sterling TR;Silverberg MJ;Deeks S;Jacobson LP;Bosch RJ;Kitahata MM;Goedert JJ;Moore R;Gange SJ;North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA
通讯作者: North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA